ArriVent BioPharma, Inc. (AVBP)

NASDAQ: AVBP · IEX Real-Time Price · USD

18.77

-0.43 (-2.24%)

At close: Jul 19, 2024, 4:30 PM

18.74

-0.03 (-0.16%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

ArriVent BioPharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	-	9.71	6.47
Research & Development	-	64.88	30.43
Operating Expenses	-	74.59	36.91
Operating Income	-	-74.59	-36.91
Other Expense / Income	-	-5.26	-
Pretax Income	-	-69.33	-36.91
Net Income	-	-69.33	-36.91
Shares Outstanding (Basic)	25	2	1
Shares Outstanding (Diluted)	-	2	1
Shares Change	1861.24%	67.64%	-
EPS (Basic)	-	-32.38	-28.90
EPS (Diluted)	-	-32.38	-28.90
Free Cash Flow	-	-55.84	-43.63
Free Cash Flow Per Share	-	-26.08	-34.16
EBITDA	-	-69.33	-36.91
EBIT	-	-69.33	-36.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).